HealthBeacon PLC HealthBeacon - HBCN - Commercial Partnership Announcement

Healthbeacon

06/09/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220906:nRSF3305Ya&default-theme=true

RNS Number : 3305Y  HealthBeacon PLC  06 September 2022

HealthBeacon announces commercial partnership with American Pharmacists
Association Foundation

 

Agreement enables novel medication adherence services in pharmacies across the
U.S.

 

Dublin, 06 September 2022: Healthbeacon plc ("HealthBeacon"), the leading
digital therapeutics company that develops products for managing medications
for patients in the home, today announces a commercial partnership with the
American Pharmacists Association Foundation ("APhA Foundation"). The
partnership will enable patients to access enhanced medication use support
through an integrated pharmacist offering with the HealthBeacon Injection Care
Management System ("ICMS") products in community pharmacies across the United
States.

Beginning in September, the partnership will enable pharmacies to offer
HealthBeacon's technology to patients on injectable medications. This will
support HealthBeacon's goal of achieving 100,000 patients using the
HealthBeacon ICMS technology by Q1 2024.

The APhA Foundation is an affiliated non-profit of the American Pharmacists
Association, the oldest, largest, national professional association of
pharmacists in the U.S. The partnership will see the APhA Foundation integrate
Pharmacist Support with the HealthBeacon ICMS technology to increase adherence
and patient outcomes. HealthBeacon's Smart Sharps Bin, Companion App,
Sustainable Waste Management and access to Data Dashboards and API data
integration will be available under the partnership.

The APhA Foundation has developed a novel adherence service called
THERxAPY(TM) which, in this initiative, integrates adherence monitoring with
community pharmacy support. This program will be implemented with support from
pharmaceutical companies and managed care plans that wish to encourage the
success of patients' adherence with prescribed injectable medications. The
HealthBeacon partnership will now see its technology integrated into the
Foundation's THERxAPY(TM) service.

Welcoming the partnership, Jim Joyce, HealthBeacon CEO, said:

"The community pharmacy setting is an excellent location for patients to
access innovative pharmacist delivered medication adherence support and tools.
Today half of all patients fail to utilize their medications as prescribed,
costing healthcare systems billions of avoidable costs and the patients their
underlying health. Together we have developed a best-in-class tech and service
offering to address this challenge and we are delighted to be working the APhA
Foundation to make this a reality.  We believe this is a positive step in
making our technology more accessible to patients across the United States and
that it will provide us with a model to deploy in other markets in the
future."

Enthusiastically about the partnership, Benjamin Bluml, RPh, APhA Foundation
Executive Director and SVP, Research & Innovation said:

"The evidence base supporting the role of the pharmacist in improving
medication adherence through patient-centered, team-based care services is
strong and continues to grow. We are committed to designing and implementing
innovative solutions that improves the lives of those we serve! The APhA
Foundation's research and innovation initiatives focus on demonstrating how
pharmacists can improve healthcare. It aims to create a new medication use
system where patients, pharmacists, physicians and other healthcare
professionals collaborate in interprofessional way to improve the cost
effectiveness and quality of patient health outcomes".

 Enquiries:
 HealthBeacon:                                    Investor.Relations@HealthBeacon.com

 Laurence Flavin

 Goodbody (Euronext Listing Sponsor and Broker):  +353 (1) 667 0420

 David Kearney
 Stephen Kane

 Drury (Public Relations):
 Cathal Barry                                     +353 (0) 87 227 9281
 Paul Clifford                                    +353 (0)87 327 2161

 

About HealthBeacon

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company
that develops products for managing medications for patients in the home. The
HealthBeacon Injection Care Management System tracks adherence and persistence
with medication schedules through the provision of medication management
reminders, safe and sustainable sharps disposal devices, educational tools,
and artificial intelligence (AI) driven data analytics. The Company operates
in 17 countries primarily across Europe, North America and the United Kingdom
employs more than 60 people and has obtained more than 30 design and utility
patents. Peer reviewed evidence demonstrated up to a 26% improvement in
injectable medication adherence by patients using its technology. The
Company's mission is to become the world's leading digital therapeutics
platform for injectable medications.

About the American Pharmacists Association (APhA) Foundation

The American Pharmacists Association (APhA) Foundation, a 501(c)(3) charitable
nonprofit organization based in Washington, D.C. works to design solutions to
optimize medication use and optimize care delivery in America. The APhA
Foundation is affiliated with the American Pharmacists Association, the oldest
and largest national professional society of pharmacists in the United States
established in 1852. The APhA Foundation's mission is to improve health by
inspiring philanthropy, research and innovation that advances pharmacists'
patient care services. For more information, please visit
www.APhAFoundation.org (http://www.APhAFoundation.org) .

About the American Pharmacists Association

The American Pharmacists Association is the only organization advancing the
entire pharmacy profession. Its expert staff, and strong volunteer leadership,
including many experienced pharmacists, allow it to deliver vital leadership
to help pharmacists, pharmaceutical scientists, student pharmacists and
pharmacy technicians find success and satisfaction in their work, while
advocating for changes that benefit them, their patients and their
communities. For more information, please visit www.Pharmacist.com
(http://www.Pharmacist.com) .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEUVRNRUVUKRAR